Natco Pharma

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue1,435651.101,2871,3911,463
Expenses616.70487.40781.40818.70849.30
EBITDA868.10215.10614.40632.70679.20
EBIT822.30168.10516.10575.10626.80
Profit Before Tax818.20163.70505.90571.90613.70
Net Profit676.50132.40406.00480.30517.90
Financial Ratios
Operating Profit Margin63.31%45.30%50.32%47.61%49.83%
Net Profit Margin49.40%28.01%33.30%36.17%38.03%
Earning Per Share (Diluted)37.817.4322.7026.8428.94
Dividends Per Share1.501.500.002.001.50